The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 17, 2013
Filed:
Jun. 19, 2008
James Burke, Santa Ana, CA (US);
Patrick M. Hughes, Aliso Viejo, CA (US);
Orilla C. Werhner, Anaheim, CA (US);
Ton C. Lin, Irvine, CA (US);
Maria Escobar, Foothill Ranch, CA (US);
Glenn Huang, Fremont, CA (US);
Kai-ming Zhang, Irvine, CA (US);
Larry A. Wheeler, Irvine, CA (US);
Rosy S. Donn, Saratoga, CA (US);
James Burke, Santa Ana, CA (US);
Patrick M. Hughes, Aliso Viejo, CA (US);
Orilla C. Werhner, Anaheim, CA (US);
Ton C. Lin, Irvine, CA (US);
Maria Escobar, Foothill Ranch, CA (US);
Glenn Huang, Fremont, CA (US);
Kai-Ming Zhang, Irvine, CA (US);
Larry A. Wheeler, Irvine, CA (US);
Rosy S. Donn, Saratoga, CA (US);
Allergan, Inc., Irvine, CA (US);
Abstract
Biocompatible intraocular microspheres and implants include an alpha-2 adrenergic receptor agonist and a polymer associated with the alpha-2 adrenergic receptor agonist to facilitate release of the alpha-2 adrenergic receptor agonist into an eye for an extended period of time. The alpha-2 adrenergic receptor agonist may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. The implants may be placed in an eye to treat or to prevent the occurrence of one or more ocular conditions, to reduce one or more symptoms of an ocular condition, such as an ocular neurosensory disorder and the like, to enhance normal retinal function and/or to lower intraocular pressure.